List of insiders holdings for Centessa Pharmaceuticals plc:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Medicxi Ventures Management (Jersey) Ltd Medicxi Ventures I LP Medicxi Co-Invest I LP Medicxi Ventures I GP Ltd Medicxi Growth I LP Medicxi Growth Co-Invest I LP Medicxi Growth I GP Ltd Medicxi Secondary I LP Medicxi Secondary Co-Invest I LP Medicxi Secondary I GP Ltd. 10% Owner | 2023-01-31 16:00:01 | 19,963,157 0 | 19,963,157 | Form 13G |
| Medicxi Ventures Management (Jersey) Ltd Medicxi Growth I LP Medicxi Growth Co-Invest I LP Medicxi Growth I GP Ltd 10% Owner | 2023-01-31 16:00:01 | 19,963,157 0 | 19,963,157 | Form 13G |
| Medicxi Ventures Management (Jersey) Ltd Medicxi Secondary I LP Medicxi Secondary Co-Invest I LP Medicxi Secondary I GP Ltd. 10% Owner | 2022-03-23 16:15:20 | 0 10,605,119 | 10,605,119 | Form 4 |
| De Rubertis Francesco Director | 2022-03-23 16:36:39 | 0 10,605,119 | 10,605,119 | Form 4 |
| INDEX VENTURES LIFE VI (JERSEY) L.P. Yucca (Jersey) SLP Index Venture Life Associates VI Ltd 10% Owner | 2022-02-14 08:07:51 | 9,961,789 0 | 9,961,789 | Form 13G |
| SAHA SAURABH Chief Executive Officer | 2025-02-04 16:56:32 | 1,286,017 38,000 | 1,324,017 | Form 4 |
| GRAINGER DAVID J Chief Innovation Officer | 2024-01-02 19:41:07 | 962,790 27,500 | 990,290 | Form 4 |
| YVER ANTOINE EVP & Chairman of Development | 2023-06-02 17:01:25 | 783,066 0 | 783,066 | Form 4 |
| Kanes Stephen Chief Medical Officer | 2025-02-04 16:57:29 | 500,000 0 | 500,000 | Form 4 |
| HUSSAIN IQBAL J General Counsel | 2025-02-04 16:56:09 | 280,386 5,500 | 285,886 | Form 4 |
| Crowley John J Chief Financial Officer | 2025-02-04 16:57:38 | 250,000 0 | 250,000 | Form 4 |
| Bush Tia L Chief Technology & Quality Ofc | 2025-02-04 16:55:46 | 246,503 0 | 246,503 | Form 4 |
| Weinhoff Gregory M Chief Business Officer | 2025-02-04 16:55:58 | 245,515 0 | 245,515 | Form 4 |
| CHAO DAVID M Chief Administrative Officer | 2025-02-04 16:55:27 | 228,507 0 | 228,507 | Form 4 |
| Califf Robert Director | 2021-05-27 20:26:55 | 208,474 0 | 208,474 | Form 3 |
| Templeman Thomas Chief Technology Officer | 2023-04-04 17:04:29 | 188,244 0 | 188,244 | Form 4 |
| Anderson Karen M. Chief People Officer | 2025-02-04 16:56:20 | 174,322 0 | 174,322 | Form 4 |
| Shahidi Javad Chief Medical Officer | 2022-11-23 17:04:15 | 165,000 0 | 165,000 | Form 4/A |
| Rotman Harris SVP Regulatory Affairs | 2024-02-02 17:03:52 | 137,625 0 | 137,625 | Form 4 |
| Thorell Marella Chief Accounting Officer | 2022-03-23 16:56:30 | 105,202 0 | 105,202 | Form 4 |
| KANTOFF AARON Director | 2021-11-18 20:30:09 | 60,000 0 | 60,000 | Form 4 |
| Kulkarni Samarth Director | 2024-06-27 16:32:22 | 48,000 0 | 48,000 | Form 4 |
| Hukkelhoven Mathias Director | 2024-06-27 16:33:12 | 48,000 0 | 48,000 | Form 4 |
| Hedley Mary Lynne Director | 2024-06-27 16:34:08 | 48,000 0 | 48,000 | Form 4 |
| GOYAL ARJUN Director | 2024-06-27 16:34:55 | 48,000 0 | 48,000 | Form 4 |
| Stuckley Carol Director | 2024-06-27 16:31:25 | 48,000 0 | 48,000 | Form 4 |
| ZBAR BRETT I W Director | 2024-06-27 16:30:36 | 48,000 0 | 48,000 | Form 4 |
| GAP (Bermuda) L.P. GENERAL ATLANTIC GENPAR (BERMUDA) L.P. General Atlantic (Lux) S.a r.l. General Atlantic GenPar (Lux) SCSp General Atlantic Cooperatief L.P. General Atlantic Partners (Lux) SCSp General Atlantic Partners (Bermuda) EU L.P. General Atlantic Partners (Bermuda) IV L.P. General Atlantic Cooperatief U.A. General Atlantic UM B.V. Director 10% Owner | 2023-06-26 19:03:37 | 0 48,000 | 48,000 | Form 4 |